2010
DOI: 10.1590/s0102-36162010000200007
|View full text |Cite
|
Sign up to set email alerts
|

Avaliação da função hepática em pacientes submetidos à artroplastia total do quadril em uso de enoxaparina

Abstract: (1) .Diversos fármacos são empregados no intuito de prevenir e tratar esses fenômenos. Dentre eles encontramse a heparina não fracionada, a heparina de baixo peso molecular, como a enoxaparina, cumarínicos e novas medicações inibidoras seletivas do fator xa (2) .A eficácia anticoagulante e a segurança quanto ao risco hemorrágico apresentam bom embasamento na literatura médica, comparando-se os diversos fármacos entre si (3)(4)(5)(6) ; porém sua segurança quanto às alterações na função hepática não é bem conh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…18 One must emphasize that the effectiveness of these measures varies according to the patient's profile, surgical technique used, operative time, 16 patient compliance, 19 as well as their clinical evaluation, since the use of ENX causes laboratory alterations in liver function, in DHL, in 53% of the cases, albeit without clinical repercussions. 20 Thus, an effective measure in preventing VTE and reducing hospital time, in addition to reducing other adverse events, is the early The contraindication for the use of pharmacological methods was: active bleeding or active peptic ulcer, use of anticoagulation, heparin allergy or thrombocytopenia, coagulopathy (thrombocytopenia < 100,000/mm³ or NR°> 1.5), uncontrolled systemic arterial hypertension (> 180 × 110 mmHg), persistent renal failure (clearance < 30 ml/min), recent intracranial or ocular surgery < 2weeks, CSF collection in the last 24 hours. Contraindications to adjuvant methods were: concomitant open fractures, severe heart failure, peripheral arterial insufficiency of the lower limbs and infection or ulcer in the lower limbs.…”
Section: Discussionmentioning
confidence: 99%
“…18 One must emphasize that the effectiveness of these measures varies according to the patient's profile, surgical technique used, operative time, 16 patient compliance, 19 as well as their clinical evaluation, since the use of ENX causes laboratory alterations in liver function, in DHL, in 53% of the cases, albeit without clinical repercussions. 20 Thus, an effective measure in preventing VTE and reducing hospital time, in addition to reducing other adverse events, is the early The contraindication for the use of pharmacological methods was: active bleeding or active peptic ulcer, use of anticoagulation, heparin allergy or thrombocytopenia, coagulopathy (thrombocytopenia < 100,000/mm³ or NR°> 1.5), uncontrolled systemic arterial hypertension (> 180 × 110 mmHg), persistent renal failure (clearance < 30 ml/min), recent intracranial or ocular surgery < 2weeks, CSF collection in the last 24 hours. Contraindications to adjuvant methods were: concomitant open fractures, severe heart failure, peripheral arterial insufficiency of the lower limbs and infection or ulcer in the lower limbs.…”
Section: Discussionmentioning
confidence: 99%